Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-04

Clinical Trial Update: SAFE Study - Septal Pacing for Atrial Fibrillation Suppression Evaluation [NA]

View source ↗

Summary

Completed clinical trial evaluating septal pacing as a strategy to suppress atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Abbott Medical Devices | Conditions: Atrial Fibrillation | NA | Status: COMPLETED